Capstone Therapeutics Corp. (CAPS)
CAPS Stock Price Chart
Explore Capstone Therapeutics Corp. interactive price chart. Choose custom timeframes to analyze CAPS price movements and trends.
CAPS Company Profile
Discover essential business fundamentals and corporate details for Capstone Therapeutics Corp. (CAPS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
28 Jan 1993
Employees
36.00
Website
https://www.capstonethx.comCEO
Matthew E. Lipman
Description
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
CAPS Financial Timeline
Browse a chronological timeline of Capstone Therapeutics Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 15 Aug 2025
EPS came in at -$0.13 falling short of the estimated -$0.07 by -85.71%, while revenue for the quarter reached $12.85M , missing expectations by -1.43%.
Earnings released on 15 May 2025
EPS came in at -$0.47 surpassing the estimated -$1.10 by +57.27%, while revenue for the quarter reached $7.90M , beating expectations by +5.04%.
Earnings released on 1 Apr 2025
EPS came in at -$7.00 , while revenue for the quarter reached $10.31M .
Earnings released on 30 Sept 2024
EPS came in at $0.22 , while revenue for the quarter reached $12.32M .
Earnings released on 29 Jun 2024
EPS came in at -$2.42 , while revenue for the quarter reached $12.89M .
Earnings released on 30 Mar 2024
EPS came in at -$7.06 , while revenue for the quarter reached $9.36M .
Earnings released on 31 Dec 2023
EPS came in at -$12.81 , while revenue for the quarter reached $9.49M .
Earnings released on 29 Sept 2023
EPS came in at -$3.86 , while revenue for the quarter reached $12.08M .
Earnings released on 30 Jun 2023
EPS came in at -$0.49 , while revenue for the quarter reached $15.17M .
Earnings released on 31 Mar 2023
EPS came in at -$7.07 , while revenue for the quarter reached $11.62M .
Earnings released on 30 Dec 2022
EPS came in at -$3.04 , while revenue for the quarter reached $11.02M .
Earnings released on 29 Sept 2022
EPS came in at $8.58 , while revenue for the quarter reached $17.72M .
Earnings released on 29 Jun 2022
EPS came in at $10.30 , while revenue for the quarter reached $19.51M .
Earnings released on 30 Mar 2022
EPS came in at -$2.31 , while revenue for the quarter reached $13.32M .
Earnings released on 30 Dec 2021
EPS came in at $9.06 , while revenue for the quarter reached $13.78M .
Earnings released on 29 Sept 2021
EPS came in at $14.08 , while revenue for the quarter reached $20.67M .
Earnings released on 29 Jun 2021
EPS came in at $19.96 , while revenue for the quarter reached $20.48M .
Earnings released on 30 Mar 2021
EPS came in at -$23.25 , while revenue for the quarter reached $11.81M .
Earnings released on 30 Dec 2020
EPS came in at $100.66 , while revenue for the quarter reached $13.76M .
Earnings released on 29 Sept 2020
EPS came in at $12.27 , while revenue for the quarter reached $17.72M .
CAPS Stock Performance
Access detailed CAPS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.